Counselling in multiple endocrine neoplasia syndromes: from individual experience to general guidelines
- 7 December 2004
- journal article
- review article
- Published by Wiley in Journal of Internal Medicine
- Vol. 257 (1) , 69-77
- https://doi.org/10.1111/j.1365-2796.2004.01429.x
Abstract
: Counselling of patients and closely related family members has to take a central place in management of hereditary diseases, like multiple endocrine neoplasia (MEN) syndromes including von Hippel‐Lindau (VHL) disease. In the strategy of health care, preventive medicine such as periodic clinical examination of families at‐risk needs a high priority, because in general it is assumed that continuity in attendance is cost‐effective. Counselling has to be based on individual medical experience of the doctor, adjusted to common guidelines and the findings in the family. Information leaflets, appropriate outpatient departments and an extensive network of specialists will facilitate continuity in care. Flow diagrams involving practical guidelines for diagnosis, treatment and follow up need to be applicable and after adjustment, should be accepted generally. Specially trained paramedics for counselling are required as a network that will guarantee periodic clinical examination and secure optimal prevention. Such paramedics will coordinate nationwide multidisciplinary guidance, and organize preventive and emergency cure for these patients. They will be supervised by expert clinicians in the field, and collaborate with specialists for social and psychological issues, patient organizations and clinical genetic centres. All of these professionals are responsible together for providing patients with up to date clinical information (via newsletters, Internet, etc.). Recently, in the Netherlands, a project was initiated to guarantee continuity in care and study the delivery of care. In order to realize this plan, funding has to be provided in the current research programme. In a future system support has to be obtained on a continuous base, preferably by the government and health care insurers and supervised by the national institute for health care.Keywords
This publication has 14 references indexed in Scilit:
- Communicating Evidence for Participatory Decision MakingJAMA, 2004
- Well informed uncertainties about the effects of treatmentsBMJ, 2004
- Lessons Learned from the Management of a Rare Genetic CancerNew England Journal of Medicine, 2003
- Early Malignant Progression of Hereditary Medullary Thyroid CancerNew England Journal of Medicine, 2003
- Genetic testing and primary care: a new ethic for a new settingNew Genetics and Society, 2003
- CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2Journal of Clinical Endocrinology & Metabolism, 2001
- CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2Journal of Clinical Endocrinology & Metabolism, 2001
- Familial medullary thyroid carcinoma: Not a distinct entity? Genotype-phenotype correlation in a large familyThe American Journal of Medicine, 1996
- Clinical Screening as Compared with DNA Analysis in Families with Multiple Endocrine Neoplasia Type 2ANew England Journal of Medicine, 1994
- Von hippel-lindau disease: New strategies in early detection and treatmentThe American Journal of Medicine, 1994